ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Clinical practice guidelines"

  • Abstract Number: 0200 • ACR Convergence 2021

    In Undifferentiated Arthritis, DMARD-treatment Intensified During the Last Decennia but Did Not Result in Improved Outcomes

    Marloes Verstappen, Xanthe Matthijssen and Annette H.M van der Helm-van Mil, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: International guidelines stress timely DMARD-initiation in early arthritis, also when classification-criteria are not yet fulfilled. Consequently, undifferentiated arthritis (UA)-patients are increasingly treated despite placebo-controlled…
  • Abstract Number: 0517 • ACR Convergence 2021

    TPMT and NUDT15 Genotype and Azathioprine Myelotoxicity in Patients with Inflammatory Conditions: Results from Real-World Clinical Practice

    Alyson Dickson1, Laura Daniel2, Jacy Zanussi1, Wei-Qi Wei1, Dale Plummer1, William Dupont3, Ge Liu1, Prathima Anandi1, Tyler Reese4, Kelly Birdwell1, Vivian Kawai5, Adriana Hung1, Qiping Feng1, Nancy J. Cox1, C. Michael Stein1 and Cecilia Chung1, 1Vanderbilt University Medical Center, Nashville, TN, 2Vanderbilt University Medical Center, Pegram, TN, 3Vanderbilt University, Nashville, TN, 4Vanderbilt University Medical Center, Madison, TN, 5Vanderbilt Universty Medical Center, Nashville, TN

    Background/Purpose: Azathioprine is frequently used for the treatment of several inflammatory conditions. However, treatment is often limited by adverse events, in particular myelotoxicity. Both thiopurine-S-methyltransferase…
  • Abstract Number: 0606 • ACR Convergence 2021

    How Might We Care for Rheumatoid Arthritis (RA) Patients Unable to See a Rheumatologist And/or Use Certain of Our Medications? Proposed Preliminary Recommendations for RA Patients Who Don’t Meet Our Established Guidelines

    Nicole Zagelbaum Ward1, Abhimanyu Amarnani1, Baljeet Rai2, Corinne Feldman1, Brett Feldman1 and Richard Panush1, 1LAC+USC Medical Center, Los Angeles, CA, 2LAC USC, Los Angeles, CA

    Background/Purpose: Physicians share responsibilities to promote social justice and assure equitable healthcare for all. Street medicine (SM) is a field dedicated to address the need…
  • Abstract Number: 0648 • ACR Convergence 2021

    Improving Post-Rituximab Hypogammaglobulinemia Risk Assessments: A Fellows’ Quality Improvement Initiative

    Beth Rutstein1, Melissa Argraves2, Atiye Bilgic Dagci2, Sarah Bayefsky2, Julia Rood2, Julie Chase3, Jay Mehta2, Melissa Lerman2, Cory Stingl4 and Jon Burnham2, 1Children's Hospital of Philadelphia, Wynnewood, PA, 2Children's Hospital of Philadelphia, Philadelphia, PA, 3The Children's Hospital of Philadelphia, Philadelphia, PA, 4Children's Hospital of Philadelphia, Durham, NC

    Background/Purpose: Hypogammaglobulinemia following rituximab therapy is a potentially severe complication that can lead to infection-related morbidity and mortality. If recognized, clinicians may prevent infections by…
  • Abstract Number: 0653 • ACR Convergence 2021

    Adherence to the 2015 ACR Guidelines for the Management of Polymyalgia Rheumatica and Screening for Osteoporosis at a Tertiary Care Medical Center

    Padmini Parameswaran1 and Michael Lucke2, 1Allegheny Health Network Medical Education Consortium, Pittsburgh, PA, 2Allegheny Health Network, Pittsburgh, PA

    Background/Purpose: Since the first description of polymyalgia rheumatica (PMR) in the early 1950s, the ideal dose and duration of glucocorticoid therapy has varied. In 2015,…
  • Abstract Number: 0658 • ACR Convergence 2021

    ACCORD: A Novel Rheumatology Transition Clinic Structure for Adolescent and Young Adult Patients with Childhood Onset Rheumatic Disease

    Rebecca Overbury1, Kelly Huynh2, Tracy Frech1, John Bohnsack1 and Aimee Hersh1, 1University of Utah, Salt Lake City, UT, 2Intermountain Health Care, Salt Lake City, UT

    Background/Purpose: The transition of health care from Pediatric to Adult providers for adolescents and young adults with childhood onset rheumatic disease continues to be associated…
  • Abstract Number: 0960 • ACR Convergence 2021

    The Childhood Arthritis and Rheumatology Research Alliance Start Time Optimization of Biologic Therapy in Polyarticular JIA (STOP-JIA) Study: 24-Month Outcomes

    Yukiko Kimura1, Sarah Ringold2, George Tomlinson3, Laura Schanberg4, Anne Dennos5, Mary Ellen Riordan6, Vincent Del Gaizo7, Katherine Murphy8, Pamela Weiss9, Brian Feldman10, Marc Natter11 and The STOP-JIA CARRA Registry Investigators12, 1Hackensack University Medical Center, New York, NY, 2Seattle Children's Hospital, Seattle, WA, 3University of Toronto, Toronto, ON, Canada, 4Duke University Medical Center, Durham, NC, 5Duke University, Durham, NC, 6Hackensack University Medical Center, Westwood, NJ, 7Childhood Arthritis & Rheumatology Research Alliance (CARRA), Whitehouse Station, NJ, 8Childhood Arthritis & Rheumatology Research Alliance (CARRA), New Orleans, LA, 9Children's Hospital of Philadelphia, Philadelphia, PA, 10The Hospital for Sick Children, Toronto, ON, Canada, 11Boston Children's Hospital, Boston, MA, 12Childhood Arthritis & Rheumatology Research Alliance (CARRA), Milwaukee, WS

    Background/Purpose: The CARRA STOP-JIA study compared the effectiveness of the CARRA Consensus Treatment Plans (CTPs) in achieving clinical inactive disease (CID) in untreated polyarticular JIA…
  • Abstract Number: 0963 • ACR Convergence 2021

    Immunogenicity of COVID-19 Vaccines in Patients with Autoimmune and Inflammatory Rheumatic Diseases (AIIRDs)

    Gordon Lam1, Andrew Laster2, Sarah McCarter2, Heather Gladue3, Ahmad Kashif2, Erin Siceloff2, Victoria Lackey3, Cheryl Robertson3, Ashley Toci2 and Leonard Calabrese4, 1Arthritis and Osteoporosis Consultants of the Carolinas, Cornelius, NC, 2Arthritis and Osteoporosis Consultants of the Carolinas, Charlotte, NC, 3Arthritis & Osteoporosis Consultants of the Carolinas, Charlotte, NC, 4Cleveland Clinic, Cleveland, OH

    Background/Purpose: AIIRD patients may have a blunted immune response to the COVID-19 vaccines, but this is largely uncharacterized as these individuals were not included in…
  • Abstract Number: 1542 • ACR Convergence 2021

    Does Adjustment to Dosing and Timing of Immunomodulatory Drugs Impact Immunogenicity of COVID19 Vaccines in Patients with Autoimmune and Inflammatory Rheumatic Disease (AIIRD)?

    Andrew Laster1, Gordon Lam1, Sarah McCarter1, Heather Gladue2, Ahmad Kashif1, Erin Siceloff1, Victoria Lackey2, Cheryl Robertson2, Ashley Toci1 and Leonard Calabrese3, 1Arthritis and Osteoporosis Consultants of the Carolinas, Charlotte, NC, 2Arthritis & Osteoporosis Consultants of the Carolinas, Charlotte, NC, 3Cleveland Clinic, Cleveland, OH

    Background/Purpose: Clinical trials leading to approval of the COVID19 vaccines did not include immunocompromised individuals. Concerns have been raised that immunogenicity of the vaccines may…
  • Abstract Number: 1717 • ACR Convergence 2021

    One Year After the Publication of the American College of Rheumatology (ACR) Guidelines for Management of Reproductive Health in Rheumatic Diseases, Has Anything Changed? An Analysis of Rheumatology Practice at a Tertiary Care Medical Center

    Yixuan Zhou1 and Sobia Hassan2, 1Rush University Medical Center, Chicago, IL, 2RUSH University, Chicago, IL

    Background/Purpose: Successful pregnancies in patients with rheumatic disease are possible when they are well-monitored, adequately treated, and planned during periods of disease quiescence. Previously, a…
  • Abstract Number: 1810 • ACR Convergence 2021

    Current Medication Practices and Preferences Among Patients with Psoriatic Arthritis (PsA)

    Monica Schwartzman1, Zafir Abutalib2 and Lisa Mandl1, 1Hospital for Special Surgery, New York, NY, 2The Hospital For Special Surgery, New York, NY

    Background/Purpose: The advent of targeted synthetics and biologics has greatly broadened the options for effective treatment in PsA. Guidelines published in 2018 by the American…
  • Abstract Number: 1623 • ACR Convergence 2020

    Improving Pneumococcal Vaccination Rates Among Immunosuppressed Adults in an Academic Rheumatology Clinic Utilizing a Nurse Driven Protocol

    Elena Joerns1, Bonnie Bermas2, Puneet Bajaj3, Nagendra Pokala1, Reuben Arasaratnam4, Joan Reisch1 and Dan (Clarie) Wang1, 1University of Texas Southwestern Medical Center, Dallas, TX, 2UTSouthwestern.edu, Dallas, TX, 3UT Southwestern, Dallas, TX, 4UT Southwestern Medical Center, Dallas, TX

    Background/Purpose: Rheumatology patients are particularly vulnerable to pneumococcal infection due to both their underlying disease and immunosuppressive therapy. Thus, quality improvement metrics include increasing pneumococcal…
  • Abstract Number: 1699 • ACR Convergence 2020

    Training Residents to ‘Choose Wisely’ When Testing for Antinuclear Antibodies

    Iman Qaiser1, Tracy Koehler1 and Richard Martin2, 1Mercy Health Saint Mary's, Grand Rapids, MI, 2Michigan State University College of Human Medicine, Grand Rapids, MI

    Background/Purpose: In many hospitals residents are the first providers to evaluate new patients. Consequently, residents often initiate the work-up of newly admitted patients. Multiple studies…
  • Abstract Number: 1741 • ACR Convergence 2020

    Does Preventive Care Matter? (in RA)

    Morgan Greenwald1, JoAnn Ball1, Shannon Lopez1, Monica Berg1 and Maria Greenwald1, 1Desert Medical Advances, Palm Desert, CA

    Background/Purpose: Preventive medical care improves morbidity and mortality. The assessment included 28,105 RA patients from prospective randomized trials.Methods: Nested data from a single site was…
  • Abstract Number: 0096 • ACR Convergence 2020

    The Bicipital Stress Test: A Maneuver to More Accurately Diagnose Bicipital Tendinitis and Its Referred Pain Patterns

    Meredith Thomley1, David Spalding2, Ana Preda-Naumescu1 and Raymond Waldrop1, 1University of Alabama at Birmingham, Birmingham, 2University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Inflammation of the bicipital tendon contributes heavily to shoulder joint morbidity. To date, diagnosis of bicipital tendinitis has relied on physical exam findings, particularly…
  • 1
  • 2
  • 3
  • 4
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies